Video Experimental Relacionado

Updated: Feb 12, 2026

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Inmunoterapias celulares y nuevas para el linfoma de Hodgkin clásico

Daniel Klein Reef¹, Natalie Sophia Grover¹

¹Division of Hematology, Department of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.

Hematology/oncology clinics of North America

|February 10, 2026

Resumen

Brentuximab vedotin y los inhibidores de PD-1 han mejorado la atención del linfoma de Hodgkin. Las nuevas inmunoterapias como las células CAR-T ofrecen nuevas esperanzas para los pacientes con enfermedad recidivante o refractaria.

Área de la Ciencia:

Oncología Oncología.
La inmunoterapia es una inmunoterapia.
Hematología Hematología.

Sus antecedentes:

Brentuximab vedotin y los inhibidores de PD-1 (nivolumab, pembrolizumab) han revolucionado el tratamiento del linfoma de Hodgkin.
Estas terapias se utilizan ahora en líneas de tratamiento anteriores.
Existen opciones limitadas para los pacientes que progresan después de brentuximab vedotina e inhibidores de punto de control.

Objetivo del estudio:

Revisar las nuevas inmunoterapias para el linfoma de Hodgkin recidivante / refractario.
Para resumir la lógica, la seguridad, la eficacia y el desarrollo de estos nuevos tratamientos.

Principales métodos:

Revisión de la literatura de las nuevas inmunoterapias.
Síntesis de datos sobre productos CAR-T, células T específicas del EBV, anticuerpos bispecíficos y combinaciones de inhibidores de puntos de control.

Principales resultados:

Las nuevas inmunoterapias son prometedoras para el linfoma de Hodgkin recidivante / refractario.
Los productos CAR-T, las células T específicas del EBV, los anticuerpos bispecíficos y las terapias combinadas están bajo investigación clínica activa.

Conclusiones:

A pesar de los avances, las necesidades no satisfechas siguen siendo para los pacientes con linfoma de Hodgkin avanzado.
Las inmunoterapias emergentes representan una frontera crítica en el manejo de la enfermedad recidivante / refractaria.

Palabras clave:

El anticuerpo bispecífico.El CAR-T es el CAR-T.CD3030 CD3030 CD3030 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 CD30 Combinación de inhibidores del punto de control en combinación.El linfoma de Hodgkin es el linfoma de Hodgkin.La inmunoterapia es una inmunoterapia.

Más Videos Relacionados

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Videos de Conceptos Relacionados

Classical Conditioning

Classical Conditioning

Associative learning, a core principle in behavioral psychology, involves forming connections between events and facilitating learned responses. This concept is vividly illustrated by classical conditioning, a process extensively studied by the Russian physiologist Ivan Pavlov. Pavlov's pioneering research on dogs' digestive systems led to the discovery that behaviors can be learned through association, laying the groundwork for classical conditioning.
Ivan Pavlov observed that dogs...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Principles of Classical Conditioning

Principles of Classical Conditioning

Classical conditioning, as described by Ivan Pavlov, is a foundational concept in associative learning, where a neutral stimulus becomes capable of eliciting a conditioned response through association with an unconditioned stimulus. The process of acquisition, where this learning occurs, and the subsequent phenomena of contiguity, contingency, generalization, discrimination, extinction, and spontaneous recovery are crucial for a comprehensive understanding of classical conditioning.
During the...

Classical Conditioning in Daily Life

Classical Conditioning in Daily Life

Classical conditioning, a fundamental principle of associative learning, explains various phenomena observed in daily life, such as fear development, the placebo effect, taste aversion, and drug habituation. These applications demonstrate the profound impact of associative learning on human behavior and physiological responses.
John B. Watson and Rosalie Rayner famously demonstrated the development of fear through classical conditioning in their experiment with Little Albert. They paired the...

Real-World Application of Classical Conditioning

Real-World Application of Classical Conditioning

Classical conditioning not only includes the initial pairing of stimuli but also extends to more complex forms, such as higher-order conditioning. Higher-order conditioning involves creating associations beyond the primary conditioned stimulus, resulting in a chain of conditioned responses.
Higher-order, or second-order, conditioning occurs when a neutral stimulus becomes associated with an already established conditioned stimulus through repeated pairings. For instance, if a dog has been...

Cellular Differentiation

Cellular Differentiation

How does a complex organism such as a human develop from a single cell? It all starts from a single fertilized egg which gives rise to a vast array of cell types, such as nerve cells, muscle cells, and epithelial cells that characterize the adult? Throughout development and adulthood, cellular differentiation leads cells to assume their final morphology and physiology. Differentiation is the process by which unspecialized cells become specialized to carry out distinct functions.
A zygote is a...